Document is current
Any future updates will be listed below
-
Authors
Ackerman, Cheri M.
Myhrvold, Cameron https://orcid.org/0000-0002-8971-184X
Thakku, Sri Gowtham
Freije, Catherine A. https://orcid.org/0000-0002-1939-3102
Metsky, Hayden C. https://orcid.org/0000-0002-8871-2349
Yang, David K. https://orcid.org/0000-0002-9972-3035
Ye, Simon H.
Boehm, Chloe K.
Kosoko-Thoroddsen, Tinna-Sólveig F.
Kehe, Jared
Nguyen, Tien G.
Carter, Amber
Kulesa, Anthony
Barnes, John R.
Dugan, Vivien G.
Hung, Deborah T.
Blainey, Paul C. https://orcid.org/0000-0002-4889-8783
Sabeti, Pardis C.
- License Information
-
More Information
Article History
Received: 20 March 2019
Accepted: 20 April 2020
First Online: 29 April 2020
Competing interests
: C.M.A., C.M., S.G.T., C.A.F., H.M., J.K., D.T.H., P.C.B., and P.C.S. are co-inventors on patent applications filed by the Broad Institute relating to work in this study. Additional related applications for intellectual property have been filed by the Broad Institute. P.C.S. is a co-founder of and consultant to Sherlock Biosciences and Board Member of Danaher Corporation, and holds equity in both companies. D.T.H. is also a co-founder of Sherlock Biosciences. In addition, P.C.B. is a consultant to and equity holder in companies in the microfluidics and life sciences industries including 10X Genomics, GALT, Celsius Therapeutics, and Next Generation Diagnostics.
